Drug transporters in the central nervous system: brain barriers and brain parenchyma considerations
- PMID: 11734619
Drug transporters in the central nervous system: brain barriers and brain parenchyma considerations
Abstract
Drug transport in the central nervous system is highly regulated not only by the blood-brain and the blood-cerebrospinal fluid barriers but also in brain parenchyma. The novel localization of drug transporters in brain parenchyma cells, such as microglia and astrocytes, suggest a reconsideration of the present conceptualization of brain barriers as it relates to drug transport. That is, the cellular membranes of parenchyma cells act as a second "barrier" to drug permeability and express transporters whose properties appear similar to those localized at the conventional brain barriers. This review will focus on the molecular characteristics, localization, and substrate specificities of several classes of well known membrane drug transporters (i.e., the organic cation, organic anion, nucleoside, P-glycoprotein, and multidrug resistance proteins) in the brain. Comparisons to similar transporters localized within the peripheral system and clinical implications of the functional expression of specific drug transport families will be discussed when appropriate. Nutrient and neurotransmitter transporters, whose characteristics have been reviewed extensively elsewhere, will not be considered in this review.
Similar articles
-
Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases.Prog Neurobiol. 2005 May;76(1):22-76. doi: 10.1016/j.pneurobio.2005.04.006. Prog Neurobiol. 2005. PMID: 16011870 Review.
-
Functional expression of drug transporters in glial cells: potential role on drug delivery to the CNS.Adv Pharmacol. 2014;71:45-111. doi: 10.1016/bs.apha.2014.06.010. Epub 2014 Aug 22. Adv Pharmacol. 2014. PMID: 25307214 Review.
-
[The blood-brain barrier and drug delivery in the central nervous system].Rev Neurol. 2010 Aug;51(3):165-74. Rev Neurol. 2010. PMID: 20645267 Review. Spanish.
-
Functional expression and localization of P-glycoprotein at the blood brain barrier.Microsc Res Tech. 2002 Jun 1;57(5):365-80. doi: 10.1002/jemt.10090. Microsc Res Tech. 2002. PMID: 12112443 Review.
-
The kidney--the body's playground for drugs: an overview of renal drug handling with selected clinical correlates.Can J Clin Pharmacol. 2003 Spring;10(1):17-23. Can J Clin Pharmacol. 2003. PMID: 12687033 Review.
Cited by
-
Predicting efflux ratios and blood-brain barrier penetration from chemical structure: combining passive permeability with active efflux by P-glycoprotein.ACS Chem Neurosci. 2013 Feb 20;4(2):361-7. doi: 10.1021/cn3001922. Epub 2012 Dec 11. ACS Chem Neurosci. 2013. PMID: 23421687 Free PMC article.
-
Drug resistance in cortical and hippocampal slices from resected tissue of epilepsy patients: no significant impact of p-glycoprotein and multidrug resistance-associated proteins.Front Neurol. 2015 Feb 18;6:30. doi: 10.3389/fneur.2015.00030. eCollection 2015. Front Neurol. 2015. PMID: 25741317 Free PMC article.
-
Improving the Brain Delivery of Chemotherapeutic Drugs in Childhood Brain Tumors.Cancers (Basel). 2019 Jun 13;11(6):824. doi: 10.3390/cancers11060824. Cancers (Basel). 2019. PMID: 31200562 Free PMC article. Review.
-
Unmasking the Role of Uptake Transporters for Digoxin Uptake Across the Barriers of the Central Nervous System in Rat.J Cent Nerv Syst Dis. 2017 Mar 15;9:1179573517693596. doi: 10.1177/1179573517693596. eCollection 2017. J Cent Nerv Syst Dis. 2017. PMID: 28469522 Free PMC article.
-
Drug interactions at the blood-brain barrier: fact or fantasy?Pharmacol Ther. 2009 Jul;123(1):80-104. doi: 10.1016/j.pharmthera.2009.03.017. Epub 2009 Apr 22. Pharmacol Ther. 2009. PMID: 19393264 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical